Processa Pharmaceuticals, Inc. Common PCSA

$1.89 +0.00% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-11-13 View →
8-K 8-K 2026-11-05 View →
8-K 8-K 2026-11-04 View →
8-K 8-K 2026-10-29 View →
DEF 14A DEF 14A 2026-10-22 View →
S-3 S-3 2026-10-09 View →
10-Q 10-Q 2026-08-14 View →
4 FORM 4 2026-08-11 View →
8-K 8-K 2026-08-04 View →
4 Insider transaction 2026-07-30 View →
8-K 8-K 2026-07-29 View →
4 FORM 4 2026-07-28 View →
4 FORM 4 2026-07-28 View →
4 FORM 4 2026-07-28 View →
4 FORM 4 2026-07-28 View →
4 FORM 4 2026-07-28 View →
4 FORM 4 2026-07-28 View →
4 FORM 4 2026-07-28 View →
4 FORM 4 2026-07-28 View →
4 FORM 4 2026-07-01 View →
4 FORM 4 2026-07-01 View →
4 FORM 4 2026-07-01 View →
4 FORM 4 2026-07-01 View →
4 FORM 4 2026-07-01 View →
4 FORM 4 2026-06-30 View →
4 FORM 4 2026-06-30 View →
4 FORM 4 2026-06-30 View →
4 FORM 4 2026-06-30 View →
DEF 14A DEF 14A 2026-06-18 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-01 View →
4 FORM 4 2026-06-01 View →
4 FORM 4 2026-06-01 View →
4 FORM 4 2026-06-01 View →
4 FORM 4 2026-06-01 View →
4 FORM 4 2026-05-19 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$1.89
Market Cap
$5.28 million
52-Week Range
$1.04 – $14.24
Average Volume
139K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.